{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18248", "batch_size": 260, "batch_pos": 56, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment reports on manufacturing uncertainty using neutral language.", "method": "llm_batch", "batch_id": "batch_2_14768", "batch_size": 260, "batch_pos": 11, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with explicit scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_17840", "batch_size": 260, "batch_pos": 201, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The question is information-seeking, not loaded or rhetorical.", "method": "llm_batch", "batch_id": "batch_4_7020", "batch_size": 260, "batch_pos": 181, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "This segment reports factual information about manufacturing capacity without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_2444", "batch_size": 260, "batch_pos": 177, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast for reassurance.", "method": "llm_batch", "batch_id": "batch_6_15168", "batch_size": 260, "batch_pos": 135, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_9444", "batch_size": 260, "batch_pos": 120, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes uncertainty about future manufacturing capability ('too early to tell how many doses... will be able to manufacture'), without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_18056", "batch_size": 260, "batch_pos": 203, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
